About
Michael Kope is a biotechnology executive and longevity-sector operator best known as a co-founder of SENS Research Foundation and its founding CEO from 2009 to 2019. He later co-founded Cyclarity Therapeutics, where he serves as CEO of Corporate Affairs and a director, helping translate SENS-derived cardiovascular aging research into a clinical-stage company. Public sources place him at the intersection of nonprofit longevity research, commercialization, and board-level ecosystem governance rather than personal investing.
Areas of interest
longevityrejuvenation biotechnologyregenerative medicinebiotech commercializationcardiovascular diseaseatherosclerosistranslational medicinenonprofit research strategy